| |
|
|
| Name: |
TCG Crossover Management LLC |
| City: |
PALO ALTO |
| State: |
CA |
| Zip: |
94301 |
| |
|
|
| Achive
data |
| View
Filing Period: |
|
|
|
|
|
|
 |
Download |
|
|
| |
| |
|
Free Registration Required For Full Results
|
|
|
| Holdings
Found :
12 |
|
View All Holdings |
Currently
Viewing:
Unchanged Positions |
|
|
Page 1 of 1 |
Menu
 |
Ticker |
Company Name |
Position
Rank |
New/Closed
Postion |
Last
Close |
Value |
Shares Held |
% of
Portfolio |
Value
Change |
Change In
Shares Held |
% of Company |
Industry |
|
AVTE |
Aerovate Therapeutics, Inc. |
6 |
- |
$0.00 |
$65,092,000 |
2,201,274 |
5.15% |
15,277,000 |
0 |
7.955 |
N/A |
|
|
INBX |
Inhibrx, Inc. |
7 |
- |
$0.00 |
$61,194,000 |
1,750,387 |
4.84% |
-5,321,000 |
0 |
3.694 |
N/A |
|
|
SVRA |
Savara Inc |
10 |
- |
$4.02 |
$49,800,000 |
10,000,000 |
3.94% |
2,800,000 |
0 |
7.389 |
Biotechnology |
|
|
TYRA |
Tyra Biosciences, Inc. |
17 |
- |
$0.00 |
$32,621,000 |
1,989,103 |
2.58% |
5,072,000 |
0 |
4.82 |
N/A |
|
|
CMPS |
Compass Pathways Plc |
18 |
- |
$0.00 |
$32,099,000 |
3,858,000 |
2.54% |
-1,659,000 |
0 |
11.083 |
N/A |
|
|
KURA |
Kura Oncology Inc |
19 |
- |
$22.06 |
$30,366,000 |
1,423,642 |
2.4% |
9,894,000 |
0 |
1.7 |
N/A |
|
|
CNTA |
Centessa Pharmaceuticals Plc |
23 |
- |
$0.00 |
$23,061,000 |
2,040,816 |
1.82% |
6,816,000 |
0 |
2.335 |
N/A |
|
|
ABVX |
Abivax S.A |
24 |
- |
$13.95 |
$15,730,000 |
1,100,000 |
1.24% |
3,960,000 |
0 |
1.774 |
N/A |
|
|
VTGN |
Vistagen Therapeutics Inc |
25 |
- |
$3.86 |
$14,132,000 |
2,676,580 |
1.12% |
374,000 |
0 |
9.902 |
Biotechnology |
|
|
CCCC |
C4 Therapeutics, Inc. |
27 |
- |
$0.00 |
$10,430,000 |
1,276,574 |
0.82% |
3,217,000 |
0 |
2.59 |
N/A |
|
|
TRDA |
Entrada Therapeutics, Inc. |
28 |
- |
$0.00 |
$8,289,000 |
584,955 |
0.66% |
-538,000 |
0 |
1.874 |
N/A |
|
|
VTYX |
Ventyx Biosciences, Inc. |
31 |
- |
$3.29 |
$4,486,000 |
815,724 |
0.35% |
2,471,000 |
0 |
1.622 |
N/A |
|
